Leila Alland Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Leila Alland.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Leila Alland. Leila Alland is a Chief Medical Officer in PMV Pharmaceuticals, Inc. ($PMVP).
Address: C/O PMV PHARMACEUTICALS, INC. 8 CLARKE DRIVE, SUITE 3 CRANBURY 08512 NJ
Companies in which Leila Alland is an Insider
PMV Pharmaceuticals, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Leila Alland: Chief Medical Officer
Holdings: 4,000 shares
Latest Transaction: Jun 08 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Leila Alland
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 08 2021 | PMVP | PMV Pharmaceutical ... | Alland Leila | Chief Medical Offic ... | Option Exercise | M | 3.90 | 4,000 | 15,600 | 365,850 | |
| Jun 08 2021 | PMVP | PMV Pharmaceutical ... | Alland Leila | Chief Medical Offic ... | Option Exercise | A | 28.33 | 36,279 | 1,027,784 | 36,279 | |
| Jun 08 2021 | PMVP | PMV Pharmaceutical ... | Alland Leila | Chief Medical Offic ... | Sell | S | 34.00 | 1,367 | 46,484 | 0 | 1.4 K to 0 (-100.00 %) |
| Jun 08 2021 | PMVP | PMV Pharmaceutical ... | Alland Leila | Chief Medical Offic ... | Sell | S | 33.39 | 2,633 | 87,903 | 1,367 | 4 K to 1.4 K (-65.82 %) |
| Jun 08 2021 | PMVP | PMV Pharmaceutical ... | Alland Leila | Chief Medical Offic ... | Buy | M | 3.90 | 4,000 | 15,600 | 4,000 | 0 to 4 K |
| May 10 2021 | PMVP | PMV Pharmaceutical ... | Alland Leila | Chief Medical Offic ... | Option Exercise | M | 3.90 | 4,000 | 15,600 | 369,850 | |
| May 10 2021 | PMVP | PMV Pharmaceutical ... | Alland Leila | Chief Medical Offic ... | Sell | S | 35.49 | 158 | 5,607 | 0 | 158 to 0 (-100.00 %) |